Cargando…
From oncolytic peptides to oncolytic polymers: A new paradigm for oncotherapy
Traditional cancer therapy methods, especially those directed against specific intracellular targets or signaling pathways, are not powerful enough to overcome tumor heterogeneity and therapeutic resistance. Oncolytic peptides that can induce membrane lysis-mediated cancer cell death and subsequent...
Autores principales: | Liu, Hanmeng, Shen, Wei, Liu, Wanguo, Yang, Zexin, Yin, Dengke, Xiao, Chunsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450358/ https://www.ncbi.nlm.nih.gov/pubmed/37637082 http://dx.doi.org/10.1016/j.bioactmat.2023.08.007 |
Ejemplares similares
-
Oncolytic immunotherapy: multiple mechanisms of oncolytic peptides to confer anticancer immunity
por: Tang, Tianyu, et al.
Publicado: (2022) -
Oncolytic Activities of Host Defense Peptides
por: Al-Benna, Sammy, et al.
Publicado: (2011) -
Oncolytic Virotherapy for Melanoma Brain Metastases, a Potential New Treatment Paradigm?
por: Soldozy, Sauson, et al.
Publicado: (2021) -
Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy
por: Pang, Yanyu, et al.
Publicado: (2018) -
Combining Oncolytic Adenovirus with Radiation—A Paradigm for the Future of Radiosensitization
por: O’Cathail, Sean M., et al.
Publicado: (2017)